Your browser doesn't support javascript.
loading
Assisting the neurologist in diagnosis of CNS malignancies - Current Possibilities and Limits of Cerebrospinal Fluid Cytology and Immunocytochemistry.
Dusková, Jaroslava; Sobek, Ondrej.
Afiliación
  • Dusková J; Institute of Pathology 1st Faculty of Medicine Charles University and Faculty General Hospital Prague Czech Republic.
  • Sobek O; Laboratory for CSF, Neuroimmunology, Pathology and Special Diagnostics Topelex Ltd Prague Czech Republic.
Brain Behav ; 7(10): e00805, 2017 10.
Article en En | MEDLINE | ID: mdl-29075565
ABSTRACT

OBJECTIVES:

In tumorous impairment of CNS, cytological identification of the neoplastic cells in CSF frequently requires the use of ancillary techniques. Our methods are focused on identifying algorithms that increase the probability of identifying CSF malignant cells. MATERIALS AND

METHODS:

A total of 1.272 CSF samples from patients with tumorous infiltration of CNS of nonhematologic origin along with 721 samples from patients with hematologic malignancies were analyzed in a complex setting including cytological and immunocytochemical investigations. RESULTS AND

DISCUSSION:

In CSF diagnostics we are aware of the limited amount of sample combined frequently with neoplastic oligocytosis. Provided atypical, potentially malignant cells in CSF are found, further investigation(s) should maximize the probability of their identification-an appropriate cytological staining and immunocytochemical panel is to be applied. (i) In cases of known recent malignancy immunoprofile of the recent neoplasm has been considered in immunocytochemical panel. (ii) In patients with a history of malignancy The propensity to develop a new different malignancy must be taken into account. (iii) Atypical cells found in the CSF of a patient with a negative history of malignancy Considering the most frequent clinically silent malignancies, stepwise immunocytochemistry is employed. Three milliliter of initial CSF sample represents the absolute minimum to start with.

CONCLUSIONS:

The steps of the laboratory activity targeted on malignancy in the CSF detection can be expected as follows (i) The sample will be divided for both nonmorphology and cytopathology investigations. (ii) Basic stainings will triage the samples into those with no suspicion of malignancy and the remaining ones. (iii) Special stainings and stepwise immunocytochemistry will be performed in parallel with the nonmorphology investigations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunohistoquímica / Líquido Cefalorraquídeo / Neoplasias del Sistema Nervioso Central Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Behav Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunohistoquímica / Líquido Cefalorraquídeo / Neoplasias del Sistema Nervioso Central Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Behav Año: 2017 Tipo del documento: Article